Phase 3 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to sign a consent form and complete the study as planned.
- People aged between 18 and 80 years old.
- People who have a good level of physical fitness and are able to carry out normal daily activities with little or no limitation (confirmed by a score of 0 or 1 on a standard fitness scale used by doctors).
- People who have not previously had surgery for lung cancer.
- People whose lung cancer has been identified during or after surgery as a type called lung adenocarcinoma.
- People who have a single lung nodule that appears as mostly or entirely "ground-glass" on a CT scan, or multiple lung nodules where the main nodule fits this description (ground-glass refers to a hazy appearance on the scan).
- People whose nodule has a specific measurement ratio (called consolidation-to-tumor ratio) between 0.25 and 0.5, and whose nodule is 2 cm or smaller in size.
- People whose nodule is located in the outer third of the lung.
- People whose cancer is at an early stage with no spread to lymph nodes or other parts of the body (referred to as cT1N0M0 by doctors).
- People whose entire tumour has been fully removed by a surgical procedure called wedge resection, as confirmed by the surgeon.
- People who have not previously received chemotherapy or radiotherapy.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose post-surgery tissue examination shows a very early form of adenocarcinoma called adenocarcinoma in situ, or a minimally invasive adenocarcinoma.
- People whose nodule measurement ratio falls outside the 0.25–0.5 range, or whose nodule is larger than 2 cm.
- People whose tumour cannot be fully removed using wedge resection surgery.
- People who have been diagnosed with a more advanced form of lung adenocarcinoma, or a lung cancer other than adenocarcinoma, based on tissue or cell testing.
- People who have previously had surgery for lung cancer.
- People who have previously received radiotherapy or chemotherapy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18813039287
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
5-year overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.